Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Machine learning can use blood tests to help predict moderate-to-severe alopecia areata.

Activating ALDH2 can boost hair growth.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

New, effective treatments for alopecia areata require innovative approaches targeting the immune system.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.

The laser therapy device effectively increased hair growth in people with androgenetic alopecia.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

JAK inhibitors are recommended for severe alopecia areata if corticosteroids fail.

Early NAS level changes affect alcohol consumption vulnerability.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

The AI model accurately classifies Alopecia Areata with 96.94% accuracy.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Apremilast did not work for treating severe alopecia areata.

Severe vitamin deficiencies in children can cause significant hair problems.

Alopecia areata in Spain has a significant impact with unmet treatment needs and high costs.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Researchers created a system that accurately aligns laser beams automatically.